Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients
Condition(s):COVID-19Last Updated:June 8, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:June 8, 2022Recruiting
Condition(s):OnchocerciasisLast Updated:December 31, 2020Completed
Condition(s):Covid19Last Updated:July 7, 2021Completed
Condition(s):COVIDLast Updated:June 24, 2020Unknown status
Condition(s):ScabiesLast Updated:March 20, 2024Recruiting
Condition(s):The Focus of the Study is to Assess the Effectiveness of Topical Ivermectin on Eliminating Eyelash SleevesLast Updated:January 28, 2022Unknown status
Condition(s):RosaceaLast Updated:October 5, 2021Completed
Condition(s):Covid19Last Updated:August 12, 2020Unknown status
Condition(s):Alcohol Use DisorderLast Updated:August 8, 2018Completed
Condition(s):Covid19; SARS (Severe Acute Respiratory Syndrome)Last Updated:April 26, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.